References
- Christin-MaitreSHistory of oral contraceptive drugs and their use worldwideBest Pract Res Clin Endocrinol Metab201327131223384741
- RosenbergMJWaughMSOral contraceptive discontinuation: a prospective evaluation of frequency and reasonsAm J Obstet Gynecol19981793 pt 15775829757954
- RosenbergMJWaughMSMeehanTEUse and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuationContraception19955152832887628201
- MoreauCBouyerJBajosNRodríguezGTrussellJFrequency of discontinuation of contraceptive use: results from a French population-based cohortHum Reprod20092461387139219252195
- KovacsGProgestogen-only pills and bleeding disturbancesHum Reprod199611suppl 220238982741
- EvansGSuttonELOral contraceptionMed Clin North Am201599347950325841596
- LawrieTHelmerhorstFMaitraNKulierRBloemenkampKGülmezogluAMTypes of progestogens in combined oral contraception: effectiveness and side-effectsCochrane Database Syst Rev20115CD00486121563141
- GrimesDALopesLMO’BrienPARaymondEGProgestin-only pills for contraceptionCochrane Database Syst Rev201311CD00754124226383
- GalloMFNandaKGrimesDALopezLMSchulzKF20 µg versus >20 µg estrogen combined oral contraceptives for contraceptionCochrane Database Syst Rev20138CD00398923904209
- PalaciosSWildtLParkeSMachlittARömerTBitzerJEfficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trialEur J Obstet Gynecol Reprod Biol20101491576219969409
- WhalenKLRoseREstradiol valerate/dienogest: a novel oral contraceptiveAnn Pharmacother201145101256126121917554
- ZeunSLuMUddinAZeilerBMorrisonDBlodeHPharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogestEur J Contracept Reprod Health Care200914322123219565420
- JensenJTParkeSMellingerUSerraniMMabeyRGJrHormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimateEur J Contracept Reprod Health Care201318427428323638631
- MacìasGMerki-FeldGSParkeSMellingerUSerraniMEffects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicenter, randomised, double-blind, active-controlled HARMONY II studyJ Obstet Gynaecol201333659159623919857
- PetragliaFParkeSSerraniMMellingerURömerTEstradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrheaInt J Gynaecol Obstet2014125327027424713413
- FraserISParkeSMellingerUMachlittASerraniMJensenJEffective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of estradiol valerate and dienogestEur J Contracept Reprod Health Care201116425826921774563
- DavisSBitzerJGiraldiAChange to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunctionJ Sex Med201310123069307924034466